Tamoxifen liposomal

Drug Profile

Tamoxifen liposomal

Alternative Names: Liposomal tamoxifen

Latest Information Update: 09 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Max-Delbruck Centre for Molecular Medicine
  • Class Antineoplastics; Chemopreventatives; Dimethylamines; Infertility therapies; Phenyl ethers; Small molecules; Stilbenes
  • Mechanism of Action Estrogen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 08 Aug 2006 No development reported - Preclinical for Breast cancer in Europe (PO)
  • 12 Nov 2001 Preclinical development for Breast cancer in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top